Abstract
Pyruvate kinase muscle type 2 (PKM2) exhibits post-translational modifications in response to various signals from the tumor microenvironment. Insulin-like growth factor 1 (IGF-1) is a crucial signal in the tumor microenvironment that promotes cell growth and survival in many human cancers. Herein, we report that AKT directly interacts with PKM2 and phosphorylates it at Ser-202, which is essential for the nuclear translocation of PKM2 protein under stimulation of IGF-1. In the nucleus, PKM2 binds to STAT5A and induces IGF-1-stimulated cyclin D1 expression, suggesting that PKM2 acts as an important factor inducing STAT5A activation under IGF-1 signaling. Concordantly, overexpression of STAT5A in cells deficient in PKM2 expression failed to restore IGF-induced growth, whereas reconstitution of PKM2 in PKM2 knockdown cells restored the IGF-induced growth capacity. Our findings suggest a novel role of PKM2 in promoting the growth of cancers with dysregulated IGF/phosphoinositide 3-kinase/AKT signaling.
Author supplied keywords
Cite
CITATION STYLE
Park, Y. S., Kim, D. J., Koo, H., Jang, S. H., You, Y. M., Cho, J. H., … Yeom, Y. I. (2016). AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth. Oncotarget, 7(30), 48155–48167. https://doi.org/10.18632/oncotarget.10179
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.